Search results for "610"

showing 10 items of 1353 documents

Characterization of PD-1 and PD-L1 Expression in Papillary Renal Cell Carcinoma: Results of a Large Multicenter Study

2021

Abstract Background Programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) play a decisive role as prognostic markers in clear-cell renal cell carcinoma (RCC). To date, the role of PD-1/PD-L1 as a prognostic marker in papillary RCC (pRCC) remains scarce. Patients and Methods Patients’ sample collection was a joint collaboration of the nationwide PANZAR consortium – a multicenter study. Medical history and tumor specimens were collected from 245 and 129 patients with pRCC types 1 and 2, respectively. Expression of PD-1 and PD-L1 was determined by immunohistochemistry in pRCC and tumor-infiltrating mononuclear cells. Results Of 374 pRCC specimens, 204 type 1 and 97 type 2 we…

Oncologymedicine.medical_specialtyUrologyProgrammed Cell Death 1 Receptor030232 urology & nephrology610DiseaseB7-H1 Antigen03 medical and health sciences0302 clinical medicineRenal cell carcinomaInternal medicinePD-L1Biomarkers TumormedicineHumansMedical historyCarcinoma Renal CellPapillary renal cell carcinomasbiologybusiness.industryPrognosismedicine.diseaseKidney NeoplasmsOncology030220 oncology & carcinogenesisCohortbiology.proteinImmunohistochemistrySample collectionbusinessClinical Genitourinary Cancer
researchProduct

Immunotherapy: New Options in Gastrointestinal Cancers?

2019

Oncologymedicine.medical_specialtybusiness.industrymedicine.medical_treatmentGastroenterologyImmunotherapyImmunotherapy Gastrointestinal CancersText miningInternal medicinemedicineSurgeryddc:610businessInterdisciplinary DiscussionVisceral Medicine
researchProduct

Thromboprophylaxis after renal transplantation and patient risk stratification: The case of mTOR inhibitors.

2020

Oncologymedicine.medical_specialtymTORiPatient risk2720 HematologyMEDLINE610 Medicine & healthStratification (mathematics)Internal medicinemedicineHumansEverolimusSirolimusEverolimusHematologybusiness.industry10031 Clinic for AngiologyTOR Serine-Threonine KinasesAnticoagulantsHematologyVenous ThromboembolismDiscovery and development of mTOR inhibitorsKidney TransplantationTransplantationRenal transplantSirolimusbusinessImmunosuppressive AgentsVenous thromboembolismmedicine.drugThrombosis research
researchProduct

Do Patients with Luminal A Breast Cancer Profit from Adjuvant Systemic Therapy? A Retrospective Multicenter Study

2016

Background Luminal A breast cancers respond well to anti-hormonal therapy (HT), are associated with a generally favorable prognosis and constitute the majority of breast cancer subtypes. HT is the mainstay of treatment of these patients, accompanied by an acceptable profile of side effects, whereas the added benefit of chemotherapy (CHT), including anthracycline and taxane-based programs, is less clear-cut and has undergone a process of critical revision. Methods In the framework of the BRENDA collective, we analyzed the benefits of CHT compared to HT in 4570 luminal A patients (pts) with primary diagnosis between 2001 and 2008. The results were adjusted by nodal status, age, tumor size and…

Oncologymedicine.medical_treatmentCancer Treatmentlcsh:MedicineBiochemistry0302 clinical medicineBreast TumorsMedicine and Health Sciences030212 general & internal medicinelcsh:ScienceAged 80 and overMultidisciplinaryPharmaceuticsHormonal TherapyEndocrine TherapyMiddle AgedSurvival RateOncologyChemotherapy Adjuvant030220 oncology & carcinogenesisFemaleAnatomyResearch Articlemedicine.drugClinical OncologyAdultmedicine.medical_specialtyAnthracyclineBreast NeoplasmsDisease-Free SurvivalLymphatic System03 medical and health sciencesBreast cancerDrug TherapyDiagnostic MedicineInternal medicineBreast CancerCancer Detection and DiagnosismedicineChemotherapyHumansddc:610Survival rateGrading (tumors)AgedRetrospective StudiesChemotherapyTaxanebusiness.industrylcsh:RCancers and NeoplasmsBiology and Life SciencesRetrospective cohort studymedicine.diseaseHormonesSurgerylcsh:QLymph NodesClinical MedicinebusinessTamoxifenPLOS ONE
researchProduct

Incidence of retinal artery occlusion in Germany

2020

Ophthalmologymedicine.medical_specialtyRetinal Artery Occlusionbusiness.industryOphthalmologyIncidence (epidemiology)610 Medical sciencesmedicine610 MedizinGeneral Medicinebusiness
researchProduct

Evolution of Photo-induced defects in Ge-doped fiber/preform: influence of the drawing

2011

International audience; We have studied the generation mechanisms of two different radiation-induced point defects, the Ge(1) and Ge(2) centers, in a germanosilicate fiber and in its original preform. The samples have been investigated before and after X-ray irradiation using the confocal microscopy luminescence and the electron paramagnetic resonance techniques. Our experimental results show the higher radiation sensitivity of the fiber as compared to the perform and suggest a relation between Ge(1) and Ge(2) generation. To explain our data we have used different models, finding that the destruction probability of the Ge(1) and Ge(2) defects is larger in fiber than in preform, whereas the …

Optical fiberMaterials sciencechemistry.chemical_elementGermanium02 engineering and technology01 natural sciencesFiber silica drawing Ge-doping defects optical absorption microluminescence electron paramagnetic resonancelaw.invention010309 opticsOpticslaw0103 physical sciencesIrradiationFiber[PHYS.PHYS.PHYS-OPTICS]Physics [physics]/Physics [physics]/Optics [physics.optics]business.industryDoping021001 nanoscience & nanotechnologyCrystallographic defectAtomic and Molecular Physics and Opticschemistry060.2310) Fiber optics; (160.2220) Defect-center materials; (300.6370) Spectroscopy microwave; (350.5610) Radiation; (300.2140) Emission.0210 nano-technologybusinessLuminescenceRefractive index
researchProduct

Long-term risk for major bleeding during extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and met…

2021

BACKGROUND The long-term risk for major bleeding in patients receiving extended (beyond the initial 3 to 6 months) anticoagulant therapy for a first unprovoked venous thromboembolism (VTE) is uncertain. PURPOSE To determine the incidence of major bleeding during extended anticoagulation of up to 5 years among patients with a first unprovoked VTE, overall, and in clinically important subgroups. DATA SOURCES MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials from inception to 23 July 2021. STUDY SELECTION Randomized controlled trials (RCTs) and prospective cohort studies reporting major bleeding among patients with a first unprovoked VTE who were to receive oral anticoagu…

Oralmedicine.medical_specialtymedicine.drug_classAdministration OralHemorrhage030204 cardiovascular system & hematologylaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawRisk FactorsInternal medicineInternal MedicineMedicineHumansCumulative incidenceAge Factor030212 general & internal medicineProspective cohort study610 Medicine & healthAdministration Oral Age Factors Aged Anticoagulants Hemorrhage Humans Middle Aged Risk Factors Venous ThromboembolismAgedbusiness.industryIncidence (epidemiology)Risk FactorAnticoagulantAge FactorsAnticoagulantsGeneral MedicineVenous ThromboembolismVitamin K antagonistMiddle Aged3. Good healthConcomitantMeta-analysisAdministrationAdministration Oral; Age Factors; Aged; Anticoagulants; Hemorrhage; Humans; Middle Aged; Risk Factors; Venous ThromboembolismbusinessCohort studyHuman
researchProduct

Short term association between ozone and mortality: global two stage time series study in 406 locations in 20 countries

2020

Objective To assess short term mortality risks and excess mortality associated with exposure to ozone in several cities worldwide. Design Two stage time series analysis. Setting 406 cities in 20 countries, with overlapping periods between 1985 and 2015, collected from the database of Multi-City Multi-Country Collaborative Research Network. Population Deaths for all causes or for external causes only registered in each city within the study period. Main outcome measures Daily total mortality (all or non-external causes only). Results A total of 45 165 171 deaths were analysed in the 406 cities. On average, a 10 µg/m3 increase in ozone during the current and previous day was associated with a…

OzoneClimate ChangeInternational CooperationShort term mortality610 Medicine & health010501 environmental sciencesGlobal Health01 natural sciences03 medical and health scienceschemistry.chemical_compoundArbetsmedicin och miljömedicin0302 clinical medicineOzone360 Social problems & social servicesEnvironmental healthAir PollutionHumans030212 general & internal medicineTime series studyCitiesMortality610 Medicine & health0105 earth and related environmental sciencesExcess mortalitySeries (stratigraphy)Ar e Saúde OcupacionalResearchGeneral MedicineOccupational Health and Environmental HealthEnvironmental ExposureTerm (time)Environmental PolicyGeographychemistryMulticenter studyAir qualityStage (hydrology)SeasonsDeterminantes da Saúde e da Doença360 Social problems & social services
researchProduct

Short term associations of ambient nitrogen dioxide with daily total, cardiovascular, and respiratory mortality: multilocation analysis in 398 cities

2021

Objective To evaluate the short term associations between nitrogen dioxide (NO2) and total, cardiovascular, and respiratory mortality across multiple countries/regions worldwide, using a uniform analytical protocol. Design Two stage, time series approach, with overdispersed generalised linear models and multilevel meta-analysis. Setting 398 cities in 22 low to high income countries/regions. Main outcome measures Daily deaths from total (62.8 million), cardiovascular (19.7 million), and respiratory (5.5 million) causes between 1973 and 2018. Results On average, a 10 μg/m3 increase in NO2 concentration on lag 1 day (previous day) was associated with 0.46% (95% confidence interval 0.36% to 0.5…

OzoneNitrogen DioxideRespiratory Tract Diseases610 Medicine & healthAir Pollutants; Air Pollution; Cardiovascular Diseases; Cities; Developed Countries; Developing Countries; Environmental Exposure; Global Health; Humans; Linear Models; Nitrogen Dioxide; Respiratory Tract Diseases; Urban HealthRespiratory MortalityHealth benefitsGlobal HealthArbetsmedicin och miljömedicinchemistry.chemical_compound360 Social problems & social servicesCardiovascular MortalityAir PollutionHumansMedicineAmbient Nitrogen DioxideNitrogen dioxideCitiesRespiratory system610 Medicine & healthDeveloping CountriesMCCAir Pollutantsbusiness.industryResearchDeveloped CountriesUrban HealthEnvironmental ExposureOccupational Health and Environmental HealthGeneral MedicineEnvironmental exposureConfidence intervalTerm (time)Increased riskchemistryambient nitrogen dioxideCardiovascular DiseasesLinear ModelsRespiratory mortalityDeterminantes da Saúde e da Doençabusiness360 Social problems & social servicesDaily MortalityDemography
researchProduct

Comment on “Worldwide Distribution of PK Deficiency: the Defect Seems Mainly Concentrated in West African Countries and the United States.”

2021

PKlcsh:RC633-647.5business.industry10031 Clinic for Angiology2720 HematologyPK DEFICIENCYDistribution (economics)610 Medicine & healthPK deficiency2725 Infectious Diseaseslcsh:Diseases of the blood and blood-forming organsHematologyUnited StatesWest African CountriesWest africanInfectious Diseases10032 Clinic for Oncology and HematologyDeficiencyMedicinebusinessSocioeconomicsLetter to the EditorMediterranean Journal of Hematology and Infectious Diseases
researchProduct